86 related articles for article (PubMed ID: 2196371)
1. Dilevalol: a dose-response study in normal volunteers.
Walden RJ; Graham BR; Liu JB; Prichard BN
J Hum Hypertens; 1990 Jun; 4 Suppl 2():69-75. PubMed ID: 2196371
[TBL] [Abstract][Full Text] [Related]
2. Clinical and biological evaluation of dilevalol vasodilating properties in mild to moderate hypertension.
Drici MD; Candito M; Ferrari E; Jacomet Y; Morand P; Lapalus P
Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):361-5. PubMed ID: 1937998
[TBL] [Abstract][Full Text] [Related]
3. The pharmacodynamics of dilevalol.
Riddell JG
J Hum Hypertens; 1990 Jun; 4 Suppl 2():39-44. PubMed ID: 2370642
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive activity and duration of action of dilevalol in hypertensive patients at rest and during exercise. A comparison with captopril.
Fogari R; Poletti L; Tettamanti F; Cesana B; Savonitto S
G Ital Cardiol; 1990 Apr; 20(4):309-15. PubMed ID: 2197158
[TBL] [Abstract][Full Text] [Related]
5. Comparative effect of propranolol and labetalol on isometric exercise and cold stress induced increase in arterial blood pressure.
Pandhi P; Sharma PL; Sharma BK; Wahi PL
Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):249-53. PubMed ID: 3525424
[TBL] [Abstract][Full Text] [Related]
6. Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.
Lammintausta R; Koulu M; Allonen H
Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):240-43. PubMed ID: 38214
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the beta 2-agonist properties of dilevalol: metabolic effects of intravenous infusion.
Kendall MJ; Lewis HM; Haffner CA; Hughes BA
J Hum Hypertens; 1990 Jun; 4 Suppl 2():65-8. PubMed ID: 2370646
[TBL] [Abstract][Full Text] [Related]
8. Effects of dilevalol (R,R-labetalol) compared with nifedipine on heart rate, blood pressure and muscle blood flow at rest and on exercise in hypertensive patients.
Walley T; Tsao Y; Scott A; Mackay E; Vandenburg M; Breckenridge A
Br J Clin Pharmacol; 1993 Jun; 35(6):623-8. PubMed ID: 8329290
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacology of dilevalol (I). Comparison of the pharmacokinetic and pharmacodynamic properties of dilevalol and labetalol after a single oral administration in healthy subjects.
Fujimura A; Ohashi K; Tsuru M; Ebihara A; Kondo K
J Clin Pharmacol; 1989 Jul; 29(7):635-42. PubMed ID: 2668352
[TBL] [Abstract][Full Text] [Related]
10. Effect of labetalol in hypertension during exercise and postural changes.
Balasubramanian V; Mann S; Millar-Craig MW; Raftery EB
Br J Clin Pharmacol; 1979; 8(Suppl 2):95S-100S. PubMed ID: 526410
[TBL] [Abstract][Full Text] [Related]
11. Effects of sildenafil on cardiopulmonary responses during stress.
Stanopoulos I; Hatzichristou D; Tryfon S; Tzortzis V; Apostolidis A; Argyropoulou P
J Urol; 2003 Apr; 169(4):1417-21. PubMed ID: 12629375
[TBL] [Abstract][Full Text] [Related]
12. Randomised, double-blind, three-way cross-over study of dilevalol 200 and 400 mg and atenolol 100 mg once-daily in patients with chronic stable angina pectoris.
Bowles MJ; Smith L; Glover DR
J Hum Hypertens; 1990 Jun; 4 Suppl 2():85-90. PubMed ID: 2196372
[TBL] [Abstract][Full Text] [Related]
13. Effects of dilevalol, propranolol and placebo on retinal blood flow, blood pressure and heart rate: a double-blind study.
Hyer SL; Kohner EM; Davies G; Mackay EM; VandenBurg MJ
J Hum Hypertens; 1990 Jun; 4 Suppl 2():63. PubMed ID: 2196370
[No Abstract] [Full Text] [Related]
14. The safety and efficacy of once-daily dilevalol in patients with mild hypertension: a placebo-controlled study.
Soberman J; Greenberg S; Frishman W
J Clin Hypertens; 1987 Sep; 3(3):271-7. PubMed ID: 3312501
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic and humoral effects at rest and after head-up tilt tests during 24-hour infusion of a new nitrate ester, ITF 296, compared with ISDN and placebo in healthy volunteers: a double-blind, randomized, within-subject study.
Sardina M; Warrington SJ; Boyce M; Johnston A; Bianchini C
J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S80-90. PubMed ID: 8839231
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive effect of dilevalol is directly related to dose and plasma concentrations.
Given BD; Perentesis G; Christopher JD; Herron J; Patrick JE; Kramer WG; Affrime MB
Am J Cardiol; 1989 Jun; 63(19):12I-16I. PubMed ID: 2729123
[TBL] [Abstract][Full Text] [Related]
17. Effect of labetalol on continuous ambulatory blood pressure.
Balasubramanian V; Mann S; Raftery EB; Millar-Craig MW; Altman D
Br J Clin Pharmacol; 1979; 8(Suppl 2):119S-123S. PubMed ID: 526391
[TBL] [Abstract][Full Text] [Related]
18. Changes in lymphocyte beta-adrenoceptor density after dilevalol oral treatment.
Sbirrazzuoli V; Drici M; Garraffo R; Candito M; Gibelin P; Morand P; Lapalus P
Drugs Exp Clin Res; 1989; 15(5):223-9. PubMed ID: 2551622
[TBL] [Abstract][Full Text] [Related]
19. The effects of a single dose of dilevalol on [3H]-noradrenaline plasma kinetics and plasma lipoprotein cholesterol concentrations.
Howes LG; Rowe PR; Krum H; Louis WJ
Br J Clin Pharmacol; 1990 Mar; 29(3):281-7. PubMed ID: 2310652
[TBL] [Abstract][Full Text] [Related]
20. Effects of oral labetalol on forearm and hepatic circulations in normotensive humans.
Sweeney MO; Cinquegrani M; Liang CS
J Lab Clin Med; 1987 May; 109(5):589-94. PubMed ID: 3572208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
